NR
National Research Corporation
NRC · NASDAQ
$20.56 -1.49% (-$0.31)
1M -6.20%
Market Cap $463.4M
P/E Ratio 79.11x
Div. Yield 2.92%
ROE 48.46%
Bulios Fair Price
$20.34
1.1% downside
Trenutna cena
$20.56
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price se delnica NRC trenutno trguje blizu svoje poštene vrednosti. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Moderate
6/9Valuation
26 /100
Expensive P/E 79.11x
EV/EBITDA 23.49x
P/S 3.31x
Growth
1 /100
Declining EPS growth 25.74%
Rev. growth 3.22%
FCF growth 15.86%
Profitability
66 /100
Moderate Gross margin 66.79%
Net margin 4.18%
Op. margin 10.53%
Quality
69 /100
Excellent ROIC 8.75%
ROE 48.46%
ROA 4.30%
Debt
20 /100
High Debt/Equity 13.75x
Current ratio 0.65x
Int. coverage 2.74x
Stability
79 /100
Stable Beta 0.38x
Rev. volatility 1.09%
EPS volatility 24.76%
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o NRC
Online
Sector
Healthcare
Industry
Medical - Healthcare Information Services
CEO
Trent Green
Employees
357
Headquarters
Lincoln
Prihajajoči dogodki
25 SEP.
Ex-Dividend
Ex-dividend date
09 OKT.
Dividend Payment
Datum plačila
26 OKT.
Earnings
Upcoming earnings report